当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › CLINICAL DRUG INVESTIGATION杂志
CLINICAL DRUG INVESTIGATION
基本信息
期刊名称 CLINICAL DRUG INVESTIGATION
CLIN DRUG INVEST
期刊ISSN 1173-2563
期刊官方网站 http://link.springer.com/journal/40261
是否OA
出版商 Adis International Ltd
出版周期 Monthly
始发年份 1995
年文章数 111
最新影响因子 3.2(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 PHARMACOLOGY & PHARMACY 药学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.04 0.731 0.744
Medicine
Pharmacology (medical)
100 / 232 57%
补充信息
自引率 2.70%
H-index 47
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
Submission to first decision
20 days
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1173-2563%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/cdia/
收稿范围

Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:

  • Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.
  • Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.

  • Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.

  • Studies focusing on the application of drug delivery technology in healthcare.

  • Short communications and case study reports that meet the above criteria will also be considered.

Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers in understanding important medical advances.

All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.


收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

Editor (Adis International Limited, Auckland, New Zealand):

Jasbir Singh

Editorial Board:

E. Battegay, University Hospital, Basel, Switzerland

E. Beghi, IRCCS Istitutodi Ricerche Farmacologiche Mario Negri, Milan, Italy

L. Bertilsson, Karolinska University Hospital, Stockholm, Sweden

H. Bhally, Waitemata District Health Board, Auckland, New Zealand

B. Brüggenjürgen, Steinbeis-University, Berlin, Germany

S.G. Carruthers, Private Practice, Lisburn, Northern Ireland

J. Chang, The University of Texas, El Paso, TX, USA

A. Chiricozzi, University of Rome Tor Vergata, Pisa, Italy

E. Christophers, University of Kiel, Kiel, Germany

K. Detyniecki, Yale University School of Medicine, New Haven, CT,USA

M.J. Eadie, University of Queensland, Brisbane, QLD, Australia

D.E. Furst, University of California at Los Angeles, Los Angeles,CA, USA

H. Giamarellou, National and Kapodistrian University of AthensMedicine School, Athens, Greece

S. Goutelle, University Hospitals of Lyon, Lyon, France

Y. Hamamoto, Kansai Electric Power Hospital, Osaka, Japan

P.D. Home, University of Newcastle upon Tyne, Newcastle upon Tyne,England

E. Jouanjus, University of Toulouse, Toulouse, France

N.M. Kaplan, University of Texas Southwestern Medical School, Dallas,TX, USA

G.L. Kearns, Scottsdale, AZ, USA

T.K.L Kiang, University of Alberta, Edmonton, ALB, Canada

F.K. Knop, Gentofte Hospital, University of Copenhagen, Hellerup,Denmark

J. Lötsch, JohannWolfgang Goethe-University, Frankfurt, Germany

G. Maconi, Luigi SaccoUniversity Hospital, Milan, Italy

H.I. Maibach, University of California San Francisco School ofMedicine, San Francisco, CA, USA

A. Marcellusi, University of Rome, Rome, Italy

T.O. Morgan, University of Melbourne, Melbourne, Vic., Australia

G.L. Morris III, Aurora BayCare Medical Center, Milwaukee, WI, USA

F.M. Muggia, NYU Cancer Institute, New York, NY, USA

M. Narukawa, Kitasato University, Tokyo, Japan

N. Pérez Álvarez, Polytechnic University of Catalonia, Barcelona,Spain

E. Perucca, University ofPavia, Pavia, Italy

E. Raschi, University of Bologna, Bologna, Italy

G. Sani, Sapienza University, Rome, Italy

S.K. Sarin, Institute of Liver and Billiary Sciences, New Delhi,India

S.C. Schachter, BethIsrael Deaconess Medical Centre, Boston, MA, USA

M. Schmitt-Egenolf, Umeå University, Umeå, Sweden

T.L. Skaer, Washington State University, Spokane, WA, USA

C. Staatz, University of Queensland, Woolloongabba, QLD, Australia

A.M. Taburet, HôpitauxUniversitaires Paris Sud, Le Kremlin Bicêtre, France

G. Trifirò, University of Messina, Messina, Italy

P. Tugwell, University of Ottawa, Ottawa, ONT, Canada

D. Veritti, University of Udine, Udine, Italy

V.T. Wong, Hong Kong University, Hong Kong, China

D. Wright, University of Otago, Dunedin, New Zealand

B. Wu, Shanghai Jiaotong University, Shanghai, China

H. Zhao, Beijing Ditan Hospital, Capital Medical University, Beijing,China


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug